RxSight, Inc. Detailed Financials

Full historical quarterly statements

Metric2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-30
Total Revenue30.9M32.6M30.3M33.6M37.9M40.2M45.4M34.9M
Cost of Goods Sold7.4M7.3M6.1M8.4M9.6M11.4M20.2M10.6M
Gross Profit23.5M25.3M24.2M25.2M28.3M28.8M25.2M24.3M
R&D Expenses9.5M8.9M9.1M10.2M10.4M9.2M8.8M8.3M
Operating Expenses41.3M36.6M36.4M39.2M39.0M37.4M34.4M32.6M
Operating Income-17.8M-11.3M-12.2M-14.0M-10.7M-8.6M-9.2M-8.3M
Other Income / Gains2.0M2.2M2.4M2.2M2.5M2.7M2.9M2.3M
Net Income-15.9M-9.2M-9.8M-11.8M-8.2M-5.9M-6.3M-6.1M
EPS (Diluted)-0.38-0.22-0.24-0.29-0.20-0.15-0.16-0.16
Reported CurrencyUSDUSDUSDUSDUSDUSDUSDUSD
Gross Profit Ratio0.7610.7750.7990.7490.7480.7160.5550.695
General And Administrative Expenses00000000
Selling And Marketing Expenses00000000
Selling General And Administrative Expenses31.9M27.7M27.3M29.0M28.6M28.2M25.6M24.3M
Other Expenses00000000
Cost And Expenses48.7M43.9M42.5M47.6M48.6M48.8M54.6M43.2M
Interest Income2.0M2.2M2.4M2.3M2.5M2.7M2.9M2.3M
Interest Expense3K5K4K5K6K5K5K6K
Depreciation And Amortization834K851K854K785K785K523K1.1M820K
Ebitda-15.0M-8.3M-8.9M-11.0M-7.4M-5.4M-5.2M-5.2M
Ebitdaratio-0.487-0.254-0.295-0.326-0.195-0.134-0.114-0.15
Operating Income Ratio-0.577-0.348-0.401-0.416-0.282-0.215-0.203-0.239
Income Before Tax-15.9M-9.1M-9.8M-11.8M-8.2M-5.9M-6.3M-6.1M
Income Before Tax Ratio-0.514-0.28-0.323-0.349-0.216-0.147-0.139-0.174
Income Tax Expense6K6K10K32K18K12K13K16K
Net Income Ratio-0.514-0.281-0.324-0.35-0.216-0.148-0.14-0.174
Epsdiluted-0.38-0.22-0.24-0.29-0.20-0.15-0.16-0.16
Weighted Average Shs Out41.3M41.2M41.0M40.7M40.5M40.4M39.8M38.5M
Weighted Average Shs Out Dil41.3M41.2M41.0M40.7M40.5M40.4M39.8M38.5M